John S. Montalbano - 07 Dec 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney in fact
Issuer symbol
ABCL
Transactions as of
07 Dec 2021
Net transactions value
$0
Form type
4
Filing time
10 Dec 2021, 12:15:57 UTC
Previous filing
17 Aug 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABCL Common Shares 26,000 07 Dec 2021 Direct
holding ABCL Common Shares 5,000 07 Dec 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Award $0 +34,282 +6.9% $0.000000 534,282 27 Aug 2021 Common Shares 34,282 $17.58 Direct
transaction ABCL Share option (right to buy) Award $0 +45,532 +8.5% $0.000000 579,814 07 Dec 2021 Common Shares 45,532 $14.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.